President & Chief Executive Officer,BVI Medical

Shervin brings to BVI over 25 years of general management, operational, financial, and investment experience across a diverse array of industries including healthcare, consumer products, industrial manufacturing and financial services. His experiences also span globally including the US and several European countries. Prior to BVI, Shervin was a senior executive with Swiss headquartered Novartis Group AG, one of the largest global healthcare companies, holding roles which included Global Head of Corporate Finance and several country/regional commercial roles. Before Novartis, he started his career and spent 15 years with The Blackstone Group, one of the world’s leading alternative investment firms, most recently as a Managing Director with experience in both the Restructuring and Private Equity businesses. In addition, Shervin is a co-founder of Sight Sciences (Nasdaq: SGHT), a growth-stage medical device company focused on transforming glaucoma and dry eye treatment. He currently serves on the Board of Directors of BVI (member of the Compensation Committee), Hain Celestial (Nasdaq: HAIN; member of the Audit Committee and Chair of the Strategy Committee) and Motus GI (Nasdaq: MOTS; Board member). In addition, Shervin serves on the Wharton Leadership Advisory Board, established by the Center for Leadership and Change Management at the University of Pennsylvania. Shervin is a graduate of the Wharton School of the University of Pennsylvania.